Background: In healthy population cohorts, resting heart rate above 90 bpm is associated with mortality from coronary heart disease, but it is not clear whether associations are present at lower heart rates or whether these associations differ between women. Methods: The CALIBER resource of linked electronic health records from primary care, hospitalisations, myocardial infarction registry and cause-specific mortality in the UK was used to assess associations between resting heart rate and 12 fatal and non-fatal coronary, cardiac, cerebral and peripheral vascular cardiovascular diseases and death using Cox proportional hazard models. Results: Among 233,970 patients, 29,690 fatal and non-fatal events occurred. Fully adjusted models showed that resting heart rate was not associated in men or women with cerebrovascular events. In men a resting heart rate of 70-79 bpm (29.1% of all men) versus less than 60 bpm was associated with an increased risk of heart failure (hazard ratio (HR) 1.65, 95% confidence interval (CI) 1.26-2.16), unheralded coronary death (HR 1.65, 95% CI 1.13-2.41), total cardiovascular events (HR 1.22, 95% CI 1.15-1.28) and all-cause mortality (HR 1.39, 95% CI 1.22-1.58). Women with a higher resting heart rate level of 80-89 bpm versus 60 bpm had a higher risk of total cardiovascular disease events (HR 1.17, 95% CI 1.07-1.24) and all-cause mortality (HR 1.21, 95% CI 1.07-1.35) compared to a resting heart rate less than 60 bpm. The risk was also present at higher heart rates (>90 bpm) for heart failure and sudden cardiac death. Conclusions: A resting heart rate that clinicians currently consider as 'normal' in the general population is specifically associated with the incidence of certain major cardiovascular diseases and death, with the risk starting at lower resting heart rate levels in men compared to women. Further research is required to evaluate whether interventions to lower resting heart rate are warranted to prevent disease. The study is registered at: clinicaltrials.gov (ID: NCT01947361).
Introduction
Heart rate is a biomarker increasingly recorded by people monitoring their own health with mobile devices and phone applications, and is an easily accessible routinely collected clinical marker in general practice. [1] [2] [3] In epidemiological studies conducted under conditions tailored for research purposes, a resting heart rate (RHR) above 90 bpm was clearly associated with mortality from coronary heart disease (CHD) 4 and all causes, 4-8 but thresholds have not been established (for public health education or clinical practice) defining a 'normal' heart rate at which the risk of cardiovascular events is at its lowest. About a third of the adult population has a RHR measured in clinical practice of 70-79 bpm, yet reliable estimates of risk at this level are lacking.
Currently, there is a lack of large-scale populationbased studies of clinically recorded RHR and it is not known whether such records replicate findings from cohorts in which heart rate is measured under research conditions. 9 Furthermore, little is known about the specificity of the associations between clinical RHR and the incidence of specific cardiovascular diseases (CVDs) with the majority of studies examining aggregated cardiovascular outcomes 4, 10 (see Supplementary  Table 1) . It is well known that women have higher RHRs than men, 7, 11 but there is a lack of sufficiently large studies powered to detect sex differences reliably.
The objectives of our research were therefore: (a) to determine the extent to which heart rate measured in clinical practice is associated with the incidence of 12 different cardiac, coronary, cerebrovascular and peripheral vascular diseases; (b) to identify potential differences in associations between women and men; and (c) to determine whether there is evidence of a threshold in risk and whether this risk extends into lower heart rate ranges. We used large-scale, population-based linked primary hospital care electronic health records (EHRs) in the ClinicAL disease research using LInked Bespoke studies and EHRs (CALIBER) resource. 12 We have previously demonstrated the validity of these data for a wide range of cardiovascular risk factors (age and sex, 13 systolic and diastolic blood pressure 14 and smoking) 15 across a wide range of incident CVDs.
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Methods
Data resource
CALIBER links patient records from four different data sources: primary care (clinical practice research database (CPRD), 16 the Myocardial Ischaemia National Audit Project registry (MINAP), 17 hospital episodes statistics (HES) 18 and the Office for National Statistics (ONS). 19 CPRD data were used to obtain heart rate measurements, demographic variables and other risk factors. CPRD patients are representative of the UK population in terms of sex, age, ethnicity 20 and overall mortality 21 and have been validated for epidemiological research. 22 A description of the CALIBER approach and phenotyping algorithms combining Read, ICD-10, drug and procedure codes to define risk factors and endpoints are available at http://www.caliberresearch.org/portal/.
Study population and heart rate
An open cohort of 233,970 people was drawn from registrants between January 1997 and March 2010 with 225 primary care practices who consented to data linkage (Supplementary Figure 1) . We included people aged 30 years and over at study entry ('index date'), with one year or more registration prior to the index date, no previous diagnosis of CVD and with at least one recorded heart rate measurement. Heart rate was prospectively recorded by general practice staff during consultations. Although the method of measurement is not recorded in the EHR, 82.6% of people with a heart rate record had a blood pressure measurement the same day, suggesting that a large proportion of heart rate measurements were obtained using an automated blood pressure device. The distributions of heart rate measured on the same and different dates as blood pressure are presented in Supplementary Figure 2 . Follow-up started from the date of their first heart rate measurement. Participants were censored on the earliest of the following dates: leaving the practice, last submission of data, death, or endpoint occurrence.
Cardiovascular risk factors
Information on cardiovascular risk factors was obtained from primary care, as recorded during consultations in primary care. Identical to previous reports we defined baseline cardiovascular risk factors using the most recent measurement (or prescription) recorded in CPRD up to one year before or on the date of study entry. Socioeconomic status was derived from the ONS using the index of multiple deprivation 2007. 23 It was divided into five categories (quintiles), the first quintile corresponding to the least deprived and the fifth quintile to the most deprived groups.
Incident cardiovascular diseases
We defined 12 CVDs identical to our previous reports 13, 14 using the four data sources to define the first occurrence of non-fatal or fatal CVDs. Additional composite endpoints analysed were total CVD events, CVD deaths and all-cause mortality. Diagnoses were identified using codes from the International Classification of Diseases 10th Revision (ICD 10) for the hospital data (HES) and mortality data (ONS), from read codes for primary care data and bespoke variables in the acute coronary syndrome registry (MINAP).
Statistical analysis
We analysed heart rate in categories (<60, 60-69, 70-79, 80-89 and >90 bpm) and used less than 60 bpm as the reference level. In addition, to explore whether digit preference might affect the results, we divided it into quintiles (30-65, 66-72, 73-79, 80-87 and 88-150 bpm). The association between heart rate and each disease was assessed using Cox proportional hazard models, adjusted for baseline age (classified by sex) as the first step and then for established cardiovascular risk factors (age, sex, social deprivation, smoking, systolic blood pressure, blood pressure-lowering medication, total cholesterol, high-density lipoprotein, low-density lipoprotein, type 2 diabetes and body mass index) and used multiple chained equations when data were missing randomly (Supplementary file 3). Sexspecific estimates are reported due to evidence of interaction with sex. Models were stratified by primary care practice. Separate analyses excluding participants prescribed beta-blockers at baseline and similarly for calcium antagonists were carried out. Further analysis was done using as the heart rate reference level the 70-79 bpm range (that is the level with the highest frequency of observations), and the heart rate of people with repeated heart rate measurements prior to their baseline measurement. To assess the shape of association between heart rate and four specific CVD endpoints in men and women, we used restricted cubic splines with three knots and the reference value of 60 bpm. Statistical analyses were performed using Stata statistical software (StataSe v13 and R version 3.0.3).
Results
Baseline characteristics
We included 233,970 patients (58% women) with heart rate measurements available at baseline with mean (SD) heart rate in men 74.6 bpm (14.5) and in women 77.9 bpm (14.0). There were 28,381 fatal and non-fatal incident cardiovascular events during 641,843.5 personyears of follow-up (mean follow-up 3.26 years). Table 1 shows that higher RHRs at baseline were associated with female sex, social deprivation, current smoking and type 2 diabetes and the lower use of beta-blockers.
Specificity of associations for different incident CVDs
In age-adjusted Cox analysis (Supplementary Table 4 ) RHR in men was associated with an increased hazard of unheralded coronary death, heart failure (HF), sudden cardiac death (SCD), myocardial infarction (MI), peripheral arterial disease (PAD), cardiovascular mortality and all-cause mortality. These were stepwise relationships with no evidence of a threshold. The fully adjusted HRs comparing a heart rate of over 90 bpm versus less than 60 bpm were particularly strong for unheralded coronary death, SCD and HF. In adjusted analyses heart rate was not associated with the incidence of coronary diseases (stable angina, unstable angina, MI in women), cerebrovascular diseases (transient ischaemic attack (TIA), subarachnoid haemorrhage, ischaemic stroke, intracerebral haemorrhage), PAD or abdominal aortic aneurysm in men or women (Figures 1 and 2 ).
Associations in women compared to men
We found strong evidence in age-adjusted (Supplementary Table 4 ) and fully adjusted analyses that men ( Figure 1 ) and women ( Figure 2 ) differed in their heart rate-CVD associations, with associations being weaker or absent in women. The fully adjusted HRs comparing a heart rate of more than 90 bpm versus less than 60 bpm were particularly strong in men for unheralded coronary death (HR 3.06, 95% confidence interval (CI) 2.07-4.52), SCD (HR 2.71, 95% CI 1.90-3.83) and HF (HR 3.26, 95% CI 2.48-4.30) whereas these associations were attenuated or not present in women (Figures 1 and 2 ). Interactions with sex were significant for stable angina, HF, unheralded coronary death, PAD, TIA, CVD death, total CVD events and all-cause mortality ( Figure 1 , Supplementary Table 4) . For stable angina, in women only heart rate above 60 bpm was associated with lower risks.
A clinical heart rate of 70-79 bpm in men (29.1% of all men) versus less than 60 bpm showed an increased risk in adjusted analyses of incident HF (HR 1.65, 95% CI 1.26-2.16), unheralded coronary death (HR 1.65, 95% CI 1.13-2.41) and PAD (HR 1.45, 95% CI 1.06-1.99), total cardiovascular events (HR 1.22, 95% CI 1.15-1.28) and all-cause mortality (HR 1.39, 95% CI 1.22-1.58) ( Figure 1 ). In women, heart rates of 70-79 bpm (31% of all women) were not associated with any disease endpoint. Women with heart rates of 80-89 bpm had higher total CVD events (HR 1.17, 95% CI 1.07-1.24) and all-cause mortality (HR 1.21, 95% CI 1.07-1.35) (Figure 2 ).
The shapes of the associations ( Figure 3 ) further highlight these important differences, the hazard of unheralded coronary death and HF increasing progressively, starting from higher heart rates in women compared to men.
Sensitivity analyses
Confining analyses to those men not prescribed betablockers showed consistent associations with a heart rate of 70-79 bpm versus less than 60 bpm and an increased risk of incident HF (HR 1.61, 95% CI 1.04-2.48) and unheralded coronary death (HR 2.87, 95% CI 1.44-5.72) (Supplementary Figures 3 and 4) . Similar findings were present when we excluded those prescribed calcium antagonists at baseline (data not shown). Removing events occurring within the first year of follow-up (as a means of addressing reverse causation) showed consistent associations in men for a heart rate of 70-79 bpm for unheralded coronary death (HR 1.85, 95% CI 1.18-2.89) and HF (HR 1.79, 95% CI 1.29-2.49) (Supplementary Figures 5  and 6 ). Analyses using repeated heart rate measurements did not alter the results ( Supplementary  Figures 7 and 8 , respectively) nor when we divided heart rate into quintiles to assess digit preference (Supplementary Figure 9) .
Discussion
Main findings
This study demonstrates the specificity of the heart rate associations across a wide range of pathologically diverse incident CVDs in clinical practice. In the largest healthy population cohort studied, we show that men have stronger associations with major cardiac diseases and mortality at lower heart rate levels than women. Figure 2 . Multivariable adjusted hazard ratios (HRs) (95% confidence intervals; CIs) for the association between heart rate and the initial presentation of 12 cardiovascular diseases and three composite outcomes in 135,599 women. CA: cardiac arrest; CV, cardioversion. *Hazard ratios from models stratified by primary care practice and adjusted for age (continuous and quadratic terms), social deprivation, smoking, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, type 2 diabetes and body mass index (covariate data and outcomes imputed). Heart rate, bpm Figure 3 . Restricted cubic splines of heart rate and heart failure, unheralded coronary death, sudden cardiac death or ventricular arrhythmia and myocardial in 233,970 men and women. Adjusted for age, social deprivation, smoking, systolic blood pressure, beta-blocker prescription, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, type 2 diabetes and body mass index and stratification by primary care.
Men
Our findings suggest that a RHR of 70-79 bpm, seen in 29.1% of men, could be associated with a CVD risk, whereas for women risk was largely confined to heart rates greater than 80 bpm.
Associations between heart rate and stroke and PAD
There was no association of heart rate with cerebrovascular manifestations or with abdominal aortic aneurysm. For PAD in men we found that risk was similarly increased at all heart rate levels above 60 bpm, with no evidence of a dose-response relation.
In contrast to a previous study by Woodward et al. 9 that used a population from the Asia-Pacific region and identified strong associations between heart rate and specific cerebrovascular outcomes, although we found strong associations with HF, CVD death and all-cause mortality, we did not find a link between heart rate (per 10 bpm increase starting above 65 bpm) and cerebrovascular events even after replicating their design and correcting for dilution bias (Supplementary Table 5 ). However, in populations with a different lifestyle background compared with western populations, the role of HR in predicting death may be different. 24 Our findings were consistent with a previous study of approximately 20 ,000 people in France that had a free medical examination provided by the national healthcare system. The level of HR did not predict stroke mortality in men nor in women regardless of the blood pressure level. 25 Associations between heart rate and contractility and rhythm disorders
In men we found a stepwise graded association between higher RHR and higher incident HF consistent with previous reports. 26, 27 In patients with established HF, randomised controlled trials of rate reduction with beta-blockers and with ivabradine have reported improvements in mortality and hospitalisation for subsequent HF events (relative risk 0.58, P < 0.001) regardless of sex. 28 The present study further examined unheralded coronary death events. These are fatal MI events in which there has been no previous CVD event diagnosed. This definition, important in public health terms, has never been studied previously in large-scale cohorts.
We found an association between RHR greater than 90 bpm and SCD, consistent with some previous reports, [29] [30] [31] particularly pertinent to events occurring within one year after the heart rate measurement. Associations of heart rate with SCD may also be consistent with experimental data showing diminishing ventricular fibrillation thresholds as heart rate is increased in stimulation studies and increasing thresholds when heart rate is lowered with ivabradine. 32 Taken together, these observations may have mechanistic implications, suggesting that damages of the myocardium and the electrical stability of the conduction system are more associated with a higher heart rate and its autonomic drivers than to disease progression in the arterial wall, despite data relating increased heart rates to a prothrombotic state, 33 endothelial dysfunction and accelerated atherosclerosis. 34 Evidence for different associations in men and women
We found strong evidence that heart rate has different associations with CVDs in women and men. We found significant sex differences for stable angina, HF, unheralded coronary death (UCD), PAD and all-cause mortality. An increased hazard of HF that was greater in men and evident at heart rates greater than 70 bpm compared with women in whom the hazard was confined to heart rates greater than 90 bpm was also identified. Epidemiological studies on RHR and HF have shown weaker associations in women, and in other smaller studies it was confined to men perhaps reflecting under-powering rather than a true sex difference. 27 Unlike HF risk that showed an increase starting at lower rates in men, SCD appeared increased when heart rate exceeded 90 bpm in both men and women. [29] [30] [31] 35, 36 This risk was still higher when restricted to those who were not on beta-blockers.
A 'normal' heart rate of 70-79 bpm showed strong associations with UCD but only in men, whereas for women the risk was not present, implying a difference in disease pattern as was also shown by the shape of their associations in Figure 3 . An increase in PAD risk present in men was found particularly for heart rates of 80-89 bpm. Women may not be at increased risk due to haemodynamic resilience and a decrease in total peripheral resistance accompanying pregnancy. 37 Lack of associations between heart rate and MI An important finding in the present study was that stepwise heart rate associations appeared to have some specificity to diseases of heart muscle and were not detected for atherothrombotic disorders, such as acute MI. In line with these findings, evidence from a clinical trial, the Study Assessing the MorbidityMortality Benefits of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease (SIGNIFY) trial showed that heart rate reduction with ivabradine does not affect the risk of MI in patients with stable coronary artery disease (CAD). 38 Mendelian randomisation studies show that the genetic loci that are associated with heart rate are not associated with CAD or MI 39 questioning the causal relevance of heart rate in these diseases.
Stable angina
Despite the plausibility of an association between RHR and the incidence of stable angina (beta-blockers were developed because of the importance of rate control in myocardial oxygen demand) there has been a lack of large-scale general population studies evaluating this question. We found that associations with stable angina were weak in men and in women there was some evidence that they were inverse (i.e. highest risk in lowest heart rate group). Restricting analyses to patients who underwent a coronary artery bypass graft (to assess more severe angina) did not alter the results (data not shown).
Clinical implications
Our findings have three clinical implications. First they can be used to help establish normal values for men and women. Approximately 63% of men have heart rates greater than 70 bpm and are at risk of major cardiovascular events and death, whereas 43% of women who have heart rates greater than 80 bpm are at increased risk of total CVD events and all-cause mortality compared to heart rates less than 60 bpm. These findings suggest that commonly considered as 'normal' heart rate values particularly in men cannot be considered harmless. Second, given the existence of behavioural (e.g. exercise) and pharmacological interventions which lower heart rate, our findings help specify the need for, and design of, endpoint trials that aim at lowering heart rate, as well as the revision of clinical guidelines in primary prevention for re-classification of HR as a greater risk factor for specific major outcomes such as HF. We found that men with RHR of 70-79 bpm who have not been prescribed beta-blocker medication were at increased risk of unheralded death and HF (Supplementary Figure 4) . Third, our findings suggest evaluation of the contribution that heart rate makes to risk prediction, taking account of specific outcomes of interest (e.g. HF) and recognising that existing tools such as SCORE and Framingham include disorders with weak or absent associations with heart rate in their aggregate CVD endpoints. 40 
Strengths and limitations
The main strength of this study lies in a populationbased large-scale cohort of 233,970 men and women with clinical resolution of 12 different CVD presentations. It is the first study to use clinical heart rate measurements recorded using EHRs, and therefore has intrinsic clinical relevance.
Our study has important limitations. Patients with a RHR recorded within CALIBER were older than those without a heart rate record (see Supplementary  Table 3 ). However, the mean heart rate values that we observed of 74 bpm in men and 77 bpm in women were similar to those reported in general population samples based on RHR measured under research conditions.
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This supports the population representativeness of CALIBER heart rate recordings. To account for potential reverse causality effects, we excluded cardiovascular events that occurred within the first year of follow-up; with the exception of SCD associations which were if anything stronger (see Supplementary Figures 5 and 6 ). In addition, EHRs lack measures of physical activity or physical fitness, which may influence RHR levels.
Conclusions
RHRs of 70-79 bpm in men in the general population were associated with a higher risk of specific major CVDs and death, while in women risks were mainly apparent at heart rates above 90 bpm. Future research should replicate our findings in other real-world cohorts, while trials of interventions to lower heart rate for primary prevention are required.
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